|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6C
|
|
pubmed:dateCreated |
2004-2-25
|
|
pubmed:abstractText |
Vinflunine is a novel Vinca alkaloid currently undergoing Phase II clinical trials, which have previously demonstrated anti-vascular effects in a transplantable murine colon adenocarcinoma model. Previous studies with compounds showing similar effects in combination with standard anti-cancer agents have demonstrated an improved efficacy relative to the standard agents.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4815-20
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14981930-Adenocarcinoma,
pubmed-meshheading:14981930-Animals,
pubmed-meshheading:14981930-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14981930-Cisplatin,
pubmed-meshheading:14981930-Colonic Neoplasms,
pubmed-meshheading:14981930-Disease Models, Animal,
pubmed-meshheading:14981930-Female,
pubmed-meshheading:14981930-Fluorouracil,
pubmed-meshheading:14981930-Mice,
pubmed-meshheading:14981930-Mice, Inbred Strains,
pubmed-meshheading:14981930-Neoplasm Transplantation,
pubmed-meshheading:14981930-Tumor Cells, Cultured,
pubmed-meshheading:14981930-Vinblastine
|
|
pubmed:articleTitle |
Vinflunine potentiates the activity of cisplatin but not 5-fluorouracil in a transplantable murine adenocarcinoma model.
|
|
pubmed:affiliation |
Cancer Research Unit, Tom Connors Cancer Research Centre, University of Bradford, Richmond Road, Bradford BD7 1DP, U.K. S.D.Shnyder@Bradford.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
